[Prostaglandin F2alpha].
Uehara
Yoshio
Y
Health Service Center, University of Tokyo.
Taguchi
Rie
R
D015415:Biomarkers / Q000032:analysis; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000209:etiology; D015237:Dinoprost / Q000031:analogs & derivatives / Q000032:analysis*; D006801:Humans; D006937:Hypercholesterolemia / Q000175:diagnosis / Q000209:etiology; D007124:Immunoenzyme Techniques / Q000379:methods; D007249:Inflammation / Q000175:diagnosis / Q000209:etiology; D007674:Kidney Diseases / Q000175:diagnosis / Q000209:etiology; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000209:etiology; D018384:Oxidative Stress; D011863:Radioimmunoassay / Q000379:methods; D012016:Reference Values; D013048:Specimen Handling
D015415:Biomarkers; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost